{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:02:43Z","timestamp":1792180963007,"version":"4.4.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The response to neoadjuvant immune checkpoint inhibition (neoICI) for mismatch repair-deficient (dMMR) colon cancer is often underestimated by radiological assessments. This study aims to develop a novel evaluation model to identify pathological complete response (pCR) and to select candidates for nonoperative management in locally advanced dMMR colon cancer following neoICI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>Patients with locally advanced dMMR colon cancer who received neoICI were enrolled from two centers in Southern China. In the discovery cohort, a novel model of immune-heralding complete response (iHCR) was developed. This model was validated in a cohort from the NEOCAP trial (NCT04715633) and another observation cohort, which included patients who adopted the nonoperative management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 156 patients with dMMR colon cancer who received neoICI were included. In the discovery cohort, 70 of 103 patients (67.9%) achieved pCR, although 92.9% still showed residual disease on CT scans. Negative endoscopic biopsy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), endoscopic tumor morphology with scar or normal mucosa (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and reductions of \u226550% in both tumor maximum diameter (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and depth (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.009) were significantly correlated with pCR. The iHCR model, integrating dynamic radiological assessments, endoscopic morphology features, and biopsy results, achieved an AUC of 0.900 (95% CI: 0.810\u20130.990) in the sub-cohort with complete endoscopic and radiological information. In the validation cohort, stepwise refinement of the model further improved the AUC to 1.00. In the observation cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a032), the iHCR model predicted sustained clinical complete response with 100% concordance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The iHCR model can effectively predict pCR and identify candidates for the nonoperative management in dMMR colon cancer following neoICI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003602","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:03:19Z","timestamp":1760457799000},"page":"3808-3817","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Proposal of a novel model for identifying complete response and nonoperative management in dMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort study"],"prefix":"10.1097","volume":"112","author":[{"given":"Le-En","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Yun","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"},{"name":"Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Hai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Rong","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hua","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Lin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Zhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jian","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Zhong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-8175","authenticated-orcid":false,"given":"Pei-Rong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"2509\u201320","DOI":"10.1056\/NEJMoa1500596","article-title":"PD 1 blockade in tumors with mismatch repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"1182\u201391","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair deficient or microsatellite instability high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"The Lancet Oncology"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"566\u201376","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"38\u201348","DOI":"10.1016\/S2468-1253(21)00348-4","article-title":"Neoadjuvant PD 1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single centre, parallel group, non comparative, randomised, phase 2 trial","volume":"7","author":"Hu","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"1949\u201358","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N Engl J Med"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"LBA3512","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3512","article-title":"Durable complete responses to PD 1 blockade alone in mismatch repair deficient locally advanced rectal cancer","volume":"42","author":"Cercek","year":"2024","journal-title":"Jco"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"176\u201384","DOI":"10.1016\/j.ejca.2022.07.016","article-title":"Anti PD 1 based immunotherapy as curative-intent treatment in dMMR\/MSI H rectal cancer: a multicentre cohort study","volume":"174","author":"Wang","year":"2022","journal-title":"Eur J Cancer"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.6004\/jnccn.2023.7096","article-title":"Long term outcomes of dMMR\/MSI-H rectal cancer treated with anti PD 1 Based immunotherapy as curative intent treatment","volume":"22","author":"Yu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"843\u201352","DOI":"10.1016\/S1470-2045(24)00203-1","article-title":"Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability high or mismatch repair-deficient colorectal cancer (NEOCAP): a single arm, open label, phase 2 study","volume":"25","author":"Yu","year":"2024","journal-title":"Lancet Oncol"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"2363\u201376","DOI":"10.1056\/NEJMoa2201445","article-title":"PD 1 blockade in mismatch repair deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"113356","DOI":"10.1016\/j.ejca.2023.113356","article-title":"Endoscopic and imaging outcomes of PD 1 therapy in localised dMMR colorectal cancer","volume":"194","author":"Fox","year":"2023","journal-title":"Eur J Cancer"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"1894\u2013903","DOI":"10.1002\/ijc.34647","article-title":"China special issue on gastrointestinal tumors Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant PD 1 blockade: a post hoc analysis of the PICC phase II trial","volume":"153","author":"Cao","year":"2023","journal-title":"Int J Cancer"},{"key":"R13-20260512","first-page":"100081","article-title":"Revised Strengthening the reporting of cohort, cross-sectional and case control studies in surgery (STROCSS) Guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Premier Journal of Science"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"The Lancet Oncology"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1676\u201378","DOI":"10.1093\/annonc\/mdx168","article-title":"irRECIST and iRECIST: the devil is in the details","volume":"28","author":"Le Lay","year":"2017","journal-title":"Ann Oncol"},{"key":"R16-20260512","first-page":"329\u201359","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"R19-20260512","first-page":"1052","article-title":"Neoadjuvant immune checkpoint inhibition improves organ preservation in t4bm0 colorectal cancer with mismatch repair deficiency: a retrospective observational study","volume":"68","author":"Han","journal-title":"Dis Colon Rectum"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"489\u201392","DOI":"10.1093\/bjs\/znac050","article-title":"Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient\/microsatellite instability high locally advanced, non metastatic colorectal cancer","volume":"109","author":"Kothari","year":"2022","journal-title":"British Journal of Surgery"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"133","DOI":"10.6004\/jnccn.2022.7071","article-title":"Prevalent pseudoprogression and pseudoresidue in patients with rectal cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"21","author":"Xie","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","article-title":"Spatiotemporal single cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer","volume":"42","author":"Chen","year":"2024","journal-title":"Cancer Cell"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"409\u201313","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD 1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ccell.2023.03.009","article-title":"Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade","volume":"41","author":"Pai","year":"2023","journal-title":"Cancer Cell"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"4633\u201340","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait and see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J Clin Oncol"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"501\u201313","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch and wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"714\u201320","DOI":"10.1111\/j.1463-1318.2011.02761.x","article-title":"Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?","volume":"14","author":"Perez","year":"2012","journal-title":"Colorectal Dis"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"33919\u201325","DOI":"10.18632\/oncotarget.5287","article-title":"The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"142\u201349","DOI":"10.1097\/DCR.0b013e31827541e2","article-title":"Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer","volume":"56","author":"Duldulao","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"3252\u201359","DOI":"10.1038\/s41388-023-02835-y","article-title":"Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer","volume":"42","author":"Kasi","year":"2023","journal-title":"Oncogene"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"285\u201396","DOI":"10.1016\/j.annonc.2024.11.016","article-title":"Tremelimumab and durvalumab as neoadjuvant or non operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO","volume":"36","author":"Raimondi","year":"2025","journal-title":"Ann Oncol"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"2297\u2013308","DOI":"10.1056\/NEJMoa2404512","article-title":"Nonoperative management of mismatch repair deficient tumors","volume":"392","author":"Cercek","year":"2025","journal-title":"N Engl J Med"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"5376\u201395","DOI":"10.7150\/jca.98723","article-title":"Bioinformatic analyses and integrated machine learning to predict prognosis and therapeutic response based on e3 ligase related genes in colon cancer","volume":"15","author":"Liang","year":"2024","journal-title":"J Cancer"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP 1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Pharmacol"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"201\u201308","DOI":"10.3923\/ijp.2024.201.208","article-title":"Interplay of USP47 and COX2 in regulating tumor microenvironment in the progression of colon cancer","volume":"20","author":"Wu","year":"2024","journal-title":"International Journal of Pharmacology"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-025-03297-8","article-title":"Extracellular matrix stiffness regulates colorectal cancer progression via HSF4","volume":"44","author":"Wang","year":"2025","journal-title":"J Exp Clin Cancer Res"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:28:50Z","timestamp":1778581730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003602","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"2025-05-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}